EP1476118A1 - Method of dispensing pharmaceutical substances - Google Patents

Method of dispensing pharmaceutical substances

Info

Publication number
EP1476118A1
EP1476118A1 EP02801386A EP02801386A EP1476118A1 EP 1476118 A1 EP1476118 A1 EP 1476118A1 EP 02801386 A EP02801386 A EP 02801386A EP 02801386 A EP02801386 A EP 02801386A EP 1476118 A1 EP1476118 A1 EP 1476118A1
Authority
EP
European Patent Office
Prior art keywords
individual
capsules
capsule
microspheres
active substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP02801386A
Other languages
German (de)
French (fr)
Other versions
EP1476118B1 (en
Inventor
David Ian Slovick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Slovick David Ian
Original Assignee
Slovick David Ian
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Slovick David Ian filed Critical Slovick David Ian
Publication of EP1476118A1 publication Critical patent/EP1476118A1/en
Application granted granted Critical
Publication of EP1476118B1 publication Critical patent/EP1476118B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
    • A61J3/074—Filling capsules; Related operations
    • G—PHYSICS
    • G07—CHECKING-DEVICES
    • G07F—COIN-FREED OR LIKE APPARATUS
    • G07F17/00—Coin-freed apparatus for hiring articles; Coin-freed facilities or services
    • G07F17/0092—Coin-freed apparatus for hiring articles; Coin-freed facilities or services for assembling and dispensing of pharmaceutical articles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J2205/00—General identification or selection means
    • A61J2205/10—Bar codes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J2205/00—General identification or selection means
    • A61J2205/20—Colour codes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J2205/00—General identification or selection means
    • A61J2205/30—Printed labels

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Basic Packing Technique (AREA)

Abstract

A device is disclosed for filling a set of capsules with microspheres containing active substances to permit the dosage of each individual active substance in each capsule of the set to be varied to suit the requirements of an individual patient. The device comprises a plurality of loading stations each receiving a canister filled with micro-spheres containing a predetermined quantity of a respective one of the active substances. A programmable metering unit associated with the loading stations meters programmed numbers of microspheres from the individual canisters, and the counted micro-spheres are introduced into the individual capsules of the set.

Description

METHOD OF DISPENSING PHARMACEUTICAL SUBSTANCES
Field of the invention
The present invention relates to the field of dispensing pharmaceutical formulations.
Background of the invention
Medicinal dosage forms (such as tablets or capsules) contain an active substance present in micro— or milli— gram amounts combined with inactive substances which promote physical or chemical stability, ease of handling and identification of the product.
Current European guidance prefers that tablets be sold in 'original dispensing packs' consisting of a metal foil laminated onto a plastic 'blister' sheet, containing a one month supply of individual tablets, affording a useful shelf life.
Patients with serious conditions such as ischaemic heart disease or congestive heart failure are required to take daily a large number of medications, which frequently results in a failure to comply accurately with the recommended prescription. This can be due to:
• forgetting pills
• confusion with dosing schedules
• unwillingness or fear of consuming large numbers of pills
• errors in taking medications resulting in running out of some pills before others.
A formal study has shown patients 'encash' prescriptions given by medical practitioners at local pharmacies for approximately 60% of the calculated total necessary number of pills, when given a regular prescription of one single tablet daily. When the prescription is for two pills daily, the encashment rate can fall to only 15%. Taking a sub-optimal number of pills would adversely affect quality of life and also reduce survival prognosis, since many treatments are life—extending, particularly when used in combination.
To mitigate this problem, it has previously been suggested that blister packing be offered as a free service by dispensing pharmacists, putting a number of tablets together in a day-coded package. However, patients are still faced with the same large number of tablets to take, which discourages them from taking their treatment reliably. Blister packing is currently performed by only a few dispensing pharmacists as a special service, and is not widely available.
It has further been proposed to manufacture tablets containing fixed dose combinations of two or more active substances. This proposal suffers from the disadvantage that fixed dose combination tablets (typically of two active substances) are recommended only for patients who have previously been stabilised on the individual components. Any particular fixed dose combination made by a manufacturer might be unsuitable or harmful for some patients, by causing metabolic disturbances or excessive or inadequate effects.
Object of the invention
The present invention therefore seeks to reduce the total number of dose forms ('pills') that patients are required to take daily.
Summary of the invention
In its broadest aspect, the present invention provides a device for filling a set of capsules with microspheres containing active substances to permit the dosage of each individual active substance in each capsule of the set to be varied to suit the requirements of an individual patient, which device comprises a plurality of loading stations each receiving a canister filled with micro-spheres containing a predetermined quantity of a respective one of the active substances, a programmable metering unit associated with the loading stations for metering programmed numbers of microspheres from the individual canisters, and means for introducing the counted micro-spheres into the individual capsules of the set.
The invention thus provides a dispensing pharmacist with the facility to mix in one capsule a combination of different active substances in absolute and relative amounts that are specifically prescribed for the patient by a medical practitioner. Not only can the doses and relative amounts of the active substances be tailored to individual patient requirements in any one set, but the different capsules within a set may contain different doses from one another, enabling a particular drug to be phased in or out over the period during which the capsules of the set are to be taken by the patient. This is referred to as titration.
Preferably, such capsules should be prepared and packed in an easily available pack for patients locally in community or hospital pharmacies.
It is important for a medical practitioner or a pharmacist to be able to ascertain the medication previously taken by a patient.
With this aim in mind, it is possible for the capsules, or their packaging if they are blister packed, to be marked with a code that permits the contained active substances and their dosage to be determined. It is preferred that the canisters should be shaped externally to provide secure mounting onto the device in a predetermined orientation and that their internal shape be such as to ensure accurate delivery of micro-spheres under gravity.
Conveniently, the canisters may be formed in two parts that seal hermetically against each other to prevent entry of water vapour or to contain a preservative gas introduced into the canisters. Such sealing of the canisters is also advantageous in that it prevents tampering.
To comply with best practice, the filled capsules may additionally be sealed into an 'original pack' for dispensing to patients.
In order to meter the correct number of micro-spheres from a supply canister into an individual capsule, it is possible to use as a programmable counter a reciprocating perforated plate, or an indented wheel, controlled by an indexing stepping mechanism. As an alternative, individual microspheres may be counted optically (by interruption of a light beam) and the flow of microspheres into a capsule may be stopped when the desired number has been reached.
For proper identification of the capsules, each capsule or more preferably the blister pack containing several capsules may be suitably encoded, for example by means of a bar code or colour coding. The encoded data may be used to identify the dispensing pharmacy, to identify the contained medications, using information stored in a database in the pharmacy.
It is not essential that the code uniquely identify the contained medications and their dosages . As the dispensing pharmacy is identified, it suffices for the pharmacy to maintain a register giving more details about the medications and conveniently such data could be accessed directly by medical practitioners and hospitals by using the Internet. Alternatively, the information could be held centrally, allowing access by approved individuals in a secure manner.
As the capsule or dispensing pack codes need not carry individual patient details, confidentiality is preserved.
The range of active substances to be formulated in microspheres is potentially wide, but would be most appropriate where the typical dose ranged from micrograms to tens of milligrams.
The external design of the manufacturers' supply canisters for the microspheres may preferably be of standardised dimensions and mechanisms for sealing/unsealing and encoding so as to ensure secure mounting into the capsule filling device and to allow positive identification of the contents of the canister through a mechanical/electrical/radio/magnetic signalling system adopting a standard code.
The internal design characteristics of the manufacturers' supply canister for the microspheres may be variable to permit adjustment of storage conditions for an adequate shelf life for the individual active substances . For example, the canisters may be filled with an inert gas, masked against entry of light, or coated to prevent water vapour entry.
The external design of the microsphere supply canisters may suitably incorporate a standardised space for labelling giving visual identification and details of contents .
Conveniently, the capsule filling device may be controlled by a computer installation that includes a printer and the computer may be programmed to print labels that give details of the dispensing pharmacy, patient name, active substance, manufacturer, expiry date and manufacturers' product codes. Such labels may be self adhesive and prepared for attachment to the original dispensing pack and to the outside of a cardboard box containing treatment supply for a 28 or 30 day period.
The original dispensing pack containing the individually filled capsules should preferably identify capsules for individual days of the week for ease of treatment compliance. Such packs may also conform to standardised dimensions and carry protrusions and/or perforations for engagement with the mechanism of an optional additional device for the extraction of the capsules from the original dispensing pack at the patients home .
Two types of extracting device such as described immediately above may be envisaged. The first may be fully automatic, containing original treatment pack for one month's supply of capsules, with ability to present the dose form to the patient at a preset time with audible tone/voice recording/ isual alert. The second may be a semi-automatic device for easy removal of the capsule from the original dispensing pack, aiding patients with low sight, reduced manual dexterity or poor memory (prompted by magnifying lens window to view day of the week on the contained original dispensing pack) .
The individual components for implementation of the invention may comprise pre-manufactured pharmaceutical capsules which are separated into component halves . The lower-parts may be inserted vertically into strips or wheels which hold twenty eight or fifty six half capsules arranged around the margin of the strip or wheel. The wheel or strip is capable of precision mounting into the capsule-filling device to allow precise filling of capsules with microspheres . A matching strip or wheel is provided to contain pre-inserted matching top-halves of the capsules. Batch closure of filled capsules is effected by application of opposing strips or wheels containing capsule upper and lower halves .
The capsule halves may be of different colours (e.g. red, orange, yellow, green, light blue, dark blue, brown, black, white, transparent, and they may have superimposed contrasting colour band(s). In this manner, colour coding may be achieved to allow the origin of the capsules to be identified. Alphanumeric codes may alternatively or additionally be pre-printed onto one half of capsule (e.g. 10 characters) and such codes may be standardised to enable national identification.
The microsphere canister will typically contain sufficient spheres for various doses for multiples of twenty eight capsules. Asymmetric shape can be used to ensure standard orientation into the capsule filling device. Labels printed onto the canister can be encoded to allow automatic transfer of details of manufacturer, active substance, dose, batch, product licence number and expiry date. The canister is sealed until insertion into the capsule filling device for security against loss of microsphere or contamination of contents .
The capsule filling device should be able to carry plastic strips or wheels containing 28 or 30 capsules and to allow mounting of up to ten manufacturers' canisters of microspheres . The filling device is microprocessor controlled for accurate dispensing of appropriate numbers of each type of microsphere into each capsule in turn. The microprocessor of the filling device should preferably be able to interface with a pharmacy computer to allow transfer of prescribing information without re-keying of prescription data to the device, and despatching of securely encoded data to distant secure database via internet connection from the device, via the pharmacy computer. The filling device may also be designed to allow future prescription data entry by barcode read directly off prescription form via the pharmacy computer or downloaded from medical practitioners' systems.
As equipment for counting microspheres is already known, for example from FR 2689092, and as equipment for filling and sealing capsules is also already known per se, for example from US 4615165, it is believed that the mechanical construction of equipment suitable for implementing the invention will be clear to the person skilled in the art without the need for further detailed description.
The invention resides not in the construction of any one of the necessary components but in the provision of a device that affords the pharmacist the flexibility to tailor the composition of the active substances in a set of capsules to the needs of an individual patient, as prescribed by a medical practitioner. In this way, a patient need only swallow one capsule at any one time, thereby ensuring that the patient adheres to the regime specified by the practitioner.

Claims

1. A device for filling a set of capsules with microspheres containing active substances to permit the dosage of each individual active substance in each capsule of the set to be varied to suit the requirements of an individual patient, which device comprises a plurality of loading stations each receiving a canister filled with micro-spheres containing a predetermined quantity of a respective one of the active substances, a programmable metering unit associated with the loading stations for metering programmed numbers of microspheres from the individual canisters, and means for introducing the counted micro-spheres into the individual capsules of the set.
2. A device as claimed in claim 1, wherein the device comprises means for separating the two parts of each capsule from one another and combining them after the lower part of the capsule has been filed.
3. A device as claimed in claim 1 or 2, wherein the metering unit is a counter that includes a reciprocating perforated plate, or an indented wheel, controlled by an indexing stepping mechanism.
4. A device as claimed in any preceding claim, wherein the loading stations have means for identifying the contents of a canister received therein from coding on the canister.
EP02801386A 2001-10-18 2002-10-14 Method of dispensing pharmaceutical substances Expired - Lifetime EP1476118B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0125064 2001-10-18
GB0125064A GB2380937A (en) 2001-10-18 2001-10-18 Method of dispensing a plurality of medical substances into capsules
PCT/GB2002/004631 WO2003032891A1 (en) 2001-10-18 2002-10-14 Method of dispensing pharmaceutical substances

Publications (2)

Publication Number Publication Date
EP1476118A1 true EP1476118A1 (en) 2004-11-17
EP1476118B1 EP1476118B1 (en) 2011-11-23

Family

ID=9924112

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02801386A Expired - Lifetime EP1476118B1 (en) 2001-10-18 2002-10-14 Method of dispensing pharmaceutical substances

Country Status (5)

Country Link
EP (1) EP1476118B1 (en)
AT (1) ATE534366T1 (en)
ES (1) ES2377516T3 (en)
GB (2) GB2380937A (en)
WO (1) WO2003032891A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014184781A1 (en) 2013-05-17 2014-11-20 David Slovick Counting device for dispensing pharmaceutical substances

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7086532B2 (en) 2003-07-16 2006-08-08 Allergan, Inc. Titration/compliance pack with increasing doses
EP2654658A4 (en) 2010-12-23 2016-04-06 Tailorpill Technologies Llc System and methods for personalized pill compounding
US10327994B2 (en) * 2016-05-02 2019-06-25 Dose Pack Llc System and methods for customized medicine dosages in a capsule

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3638688A (en) * 1970-02-24 1972-02-01 Brunswick Corp Coded oral solids magazine and dispenser
IT1203137B (en) * 1978-11-09 1989-02-15 Facchini Libero CONTINUOUS MOVING OPERATING MACHINE FOR THE PACKAGING OF PULVERULENT OR GRANULAR PRODUCTS
BR8300014A (en) * 1982-01-07 1983-08-30 Uss Eng & Consult APPLIANCE FOR MANUFACTURE OF LEADING ELEMENT CARTRIDGES
IT1171950B (en) * 1983-09-30 1987-06-10 Mg 2 Spa PROCEDURE FOR THE FEEDING, ORIENTATION, FILLING, CLOSING AND EXPULSION OF CAPSULES AND PLANT THAT IMPLEMENTS THIS PROCEDURE
JPH0620919B2 (en) * 1987-06-18 1994-03-23 日本エランコ株式会社 Method and device for filling granular material into hard capsule
FR2689092B1 (en) * 1992-03-31 1994-12-30 Boiron Device for counting a determined number of beads or the like, then for grouping them in a container.
EP0587085A3 (en) * 1992-09-11 1994-09-14 Ihde Stefan Klaus Alfred Method and device for dosing and mixing multicomponent material
SE9600070D0 (en) * 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
IE970731A1 (en) * 1997-10-07 2000-10-04 Fuisz Internat Ltd Product and method for the treatment of hyperlipidemia
US5960609A (en) * 1998-06-12 1999-10-05 Microdose Technologies, Inc. Metering and packaging method and device for pharmaceuticals and drugs
US6183779B1 (en) * 1999-03-22 2001-02-06 Pharmascience Inc. Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin
CA2366791A1 (en) * 1999-04-06 2000-10-12 Kamal K. Midha Pharmaceutical dosage form for pulsatile delivery of d-threo-methylphenidate and a second cns stimulant
IL147826A0 (en) * 1999-07-30 2002-08-14 Smithkline Beecham Plc Multi-component pharmaceutical dosage form
BR9905261A (en) * 1999-09-30 2001-07-24 Libbs Farmaceutica Ltda A new programmed-release drug association
DE19951504C2 (en) * 1999-10-26 2002-02-21 3M Espe Ag Mixing device and method
US20040172169A1 (en) * 2001-03-02 2004-09-02 Curtis Wright Method and apparatus for compouding individualized dosege forms

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO03032891A1 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014184781A1 (en) 2013-05-17 2014-11-20 David Slovick Counting device for dispensing pharmaceutical substances

Also Published As

Publication number Publication date
WO2003032891A1 (en) 2003-04-24
GB2380937A (en) 2003-04-23
GB0408460D0 (en) 2004-05-19
GB0125064D0 (en) 2001-12-12
EP1476118B1 (en) 2011-11-23
ATE534366T1 (en) 2011-12-15
GB2397763A (en) 2004-08-04
ES2377516T3 (en) 2012-03-28

Similar Documents

Publication Publication Date Title
US7712288B2 (en) Unified ingestion package and process for patient compliance with prescribed medication regimen
Cramer Enhancing patient compliance in the elderly: role of packaging aids and monitoring
JP5081835B2 (en) Pack, pack method and pack manufacturing apparatus for pharmaceutical products and the like
US6779663B1 (en) System and method for loading pills into a pillbox
US4926572A (en) Medication timing device
AU2311701A (en) Automated portable medication radial dispensing apparatus and method using a carrier type
CA2516047A1 (en) Drug administration kit
US11443840B1 (en) Medication adherence apparatus
US7793836B2 (en) Medicine management methods and apparatus
US20130161207A1 (en) Child Resistant Packaging for Multi-Prescription Order
JP2009520536A5 (en)
KR20070012509A (en) Universal medication carrier
US20040064215A1 (en) Pharmaceutical dispenser system
US20040148054A1 (en) Method and system for packaging and dispensing medication
US10327994B2 (en) System and methods for customized medicine dosages in a capsule
US7370795B2 (en) Medicine management methods and apparatus
JP7161682B2 (en) Drug placement confirmation system
EP1476118B1 (en) Method of dispensing pharmaceutical substances
US20200165022A1 (en) An apparatus and method for automated sorting and enveloping of homogeneous and/or heterogeneous substances
US20090057183A1 (en) Medication Dispensing System
GB2266978A (en) An electronic dosage reminder
WO2014184781A1 (en) Counting device for dispensing pharmaceutical substances
JP3068718U (en) Medicine bag
US20220142861A1 (en) Prescription medicine packaging system and method for using same to provide range of compliance options
JP2000043898A (en) Classified medicine pack and medicine instruction displaying medicine information for classified medicine pack

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040831

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

17Q First examination report despatched

Effective date: 20080711

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 60241631

Country of ref document: DE

Effective date: 20120119

REG Reference to a national code

Ref country code: NL

Ref legal event code: T3

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2377516

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20120328

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: MEYER & KOLLEGEN

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120224

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120323

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120223

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 534366

Country of ref document: AT

Kind code of ref document: T

Effective date: 20111123

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20120824

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 60241631

Country of ref document: DE

Effective date: 20120824

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20121031

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20121014

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 14

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 15

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 16

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IE

Payment date: 20191025

Year of fee payment: 18

Ref country code: NL

Payment date: 20191028

Year of fee payment: 18

Ref country code: DE

Payment date: 20191101

Year of fee payment: 18

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20191025

Year of fee payment: 18

Ref country code: FR

Payment date: 20191025

Year of fee payment: 18

Ref country code: ES

Payment date: 20191113

Year of fee payment: 18

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20191023

Year of fee payment: 18

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20191021

Year of fee payment: 18

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 60241631

Country of ref document: DE

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: NL

Ref legal event code: MM

Effective date: 20201101

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20201014

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201031

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210501

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201101

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201031

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201031

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201014

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201014

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201014

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20220121

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201015